Experienced in Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy (APECED)

Lyndell L. Lim

32 Gisborne Street, 
East Melbourne, VIC, AU 
Experienced in Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy (APECED)
32 Gisborne Street, 
East Melbourne, VIC, AU 
OverviewLocationsClinical Research

Overview

Lyndell Lim practices in East Melbourne, Australia. Lim is rated as an Experienced expert by MediFind in the treatment of Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy (APECED). Their top areas of expertise are Uveitis, Diabetic Macular Edema (DME), Episcleritis, Cataract Removal, and Tissue Biopsy.

Their clinical research consists of co-authoring 124 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 1 article in the study of Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy (APECED).

Locations

32 Gisborne Street, East Melbourne, VIC, Australia

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

Adalimumab vs. Conventional Immunosuppression for Uveitis Trial
Adalimumab vs. Conventional Immunosuppression for Uveitis Trial
Enrollment Status: Completed
Publish Date: May 16, 2025
Intervention Type: Biological, Drug
Study Drugs: Adalimumab, Conventional immunosuppression
Study Phase: Phase 3
Adalimumab in Juvenile Idiopathic Arthritis-associated Uveitis Stopping Trial
Adalimumab in Juvenile Idiopathic Arthritis-associated Uveitis Stopping Trial
Enrollment Status: Completed
Publish Date: May 11, 2025
Intervention Type: Other, Biological
Study Drug: Adalimumab
Study Phase: Phase 4
First-line Antimetabolites as Steroid-sparing Treatment (FAST) Uveitis Trial
First-line Antimetabolites as Steroid-sparing Treatment (FAST) Uveitis Trial
Enrollment Status: Completed
Publish Date: April 02, 2024
Intervention Type: Drug
Study Phase: Phase 3
Macular Edema Ranibizumab v. Intravitreal Anti-inflammatory Therapy Trial
Macular Edema Ranibizumab v. Intravitreal Anti-inflammatory Therapy Trial
Enrollment Status: Completed
Publish Date: July 10, 2023
Intervention Type: Drug
Study Drugs: Dexamethasone Intravitreal Implant, Intravitreal Methotrexate, Intravitreal Ranibizumab
Study Phase: Phase 3
A Phase IV Randomised Clinical Trial of Laser Therapy for Peripheral Retinal Ischaemia Combined With Intravitreal Aflibercept (Eylea®) Versus Intravitreal Aflibercept Monotherapy for Diabetic Macular Oedema
A Phase IV Randomised Clinical Trial of Laser Therapy for Peripheral Retinal Ischaemia Combined With Intravitreal Aflibercept (Eylea®) Versus Intravitreal Aflibercept Monotherapy for Diabetic Macular Oedema
Enrollment Status: Completed
Publish Date: May 31, 2022
Intervention Type: Procedure, Drug
Study Drug: Aflibercept
Study Phase: Phase 4
A Multicentre Clinical Trial of Switching Between Intravitreal Bevacizumab (Avastin®) and Intravitreal Dexamethasone (Ozurdex™) for Persistent Diabetic Macular Oedema (SwitchDMO)
A Multicentre Clinical Trial of Switching Between Intravitreal Bevacizumab (Avastin®) and Intravitreal Dexamethasone (Ozurdex™) for Persistent Diabetic Macular Oedema (SwitchDMO)
Enrollment Status: Completed
Publish Date: November 13, 2018
Intervention Type: Drug
Study Phase: Phase 2
View 5 Less Clinical Trials

124 Total Publications

Adherence to the recommended diabetic retinopathy screening guidelines in pregnant women with pregestational diabetes: a cross-sectional survey study.
Adherence to the recommended diabetic retinopathy screening guidelines in pregnant women with pregestational diabetes: a cross-sectional survey study.
Journal: BMJ open
Published: September 30, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Lim's expertise for a condition
ConditionClose
View All 9 Advanced Conditions
View All 26 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile